17 February 2022>: Articles
Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Management of emergency care, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)
Sara Al-Rasbi A , Juhaina Salim Al-Mqbali A* , Rajaa Al-Farsi B , Moza Ali Al Shukaili B , Maryam H. Al-Riyami E , Zubaida Al Falahi E , Hatem Al Farhan A , Abdullah M. Al Alawi ADOI: 10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399
Table 3. Results summary of the hospitalization autoimmune tests.
Test | Result |
---|---|
Anti-nuclear antibody (ANA) | Negatives |
Anti-Glomerular Basement Membrane Disease (Goodpasture’s Syndrome) | Negative |
Autoimmune antiphospholipid syndrome | Negative |
Anti-neutrophils cytoplasmic antibody | Negative |